Ranbaxy now faces heat at home

Health ministry seeks report from drug controller in a month

pankaj

Pankaj Kumar | May 25, 2013



Ranbaxy, punished by a US court this month for quality violations in drug manufacturing, now faces heat at home. The health ministry has asked the drug controller general of India to examine the documents, dossiers and the approval given to the largest pharma firm of the country.


"Regulators will evaluate all the documents related to Ranbaxy to see weather the quality control mechanism has been taken care of fully as per norms in seeking approvals by Ranbaxy," a senior health ministry officer told Governance Now.

A report is expected to be prepared in a month. However, the question remains why Indian authorities took no action when there was uproar in parliament over this issue after US FDA leveled charges against Ranbaxy in 2008.

The ministry had probed the matter in late 2008 but decided not to ban the drugs manufactured at two of the Ranbaxy facilities at Dewas and Paonta Sahib. In fact, the drug controller had inspected the two facilities and found nothing objectionable.

Comments

 

Other News

How Rafi, Raj Kapoor helped pave the way for a great uranium deal

There`s a certain moment in diplomacy that`s too personal to be captured in a communiqué, too small to make the front page, but more revealing than the front page. This week, prime minister Narendra Modi reached Tashkent and, amid the pomp of state visits, managed to evoke the old Bollywood tunes

Distinguishing Fish 1 and Fish 2: The pragmatism behind India’s WTO ratification

 India became the 123rd WTO member to ratify the multilateral Agreement on Fisheries subsidies (AoFS) when it deposited the Instrument of Acceptance for Phase 1 on July 20, 2026. The ratification is restricted to disciplining Illegal, Unreported and Unregulated fishing (IUU), protection for overfished

The 7% growth problem: Why the next 7% will be harder

India has become accustomed to hearing the 7% growth number. It is now less a milestone than an expectation. Yet the paradox is becoming clearer: maintaining 7% growth may be considerably harder than achieving it once. India’s real GDP grew 7.7% in FY2025–26, following growth of 6.5% in FY202

The Constitution cannot be altered: Justice Abhay Oka

Justice Abhay Oka, who retired from the Supreme Court in May 2025, has said that the Constitution of India cannot be altered. Explaining the landmark Kesavananda Bharati judgment (1973) on the basic structure of the Constitution, he said, “This is one judgment that has saved democracy in India.&rdq

How the flora and fauna evolved in the Indian subcontinent

Mammals of India  By A.J.T. Johnsingh and P.O. Nameer HarperCollins India in association with Bombay Natural History Society  

India`s renewable race is moving beyond megawatts

When Shell bought Sprng Energy in 2022, India`s renewable energy market appeared to offer precisely what global energy majors were seeking: scale, growth and a place in one of the world`s largest energy transitions. Four years later, Shell is selling the same business to Aditya Birla Group for an enterpris

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter